These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4218008)

  • 1. [Preparative separation of toxin and prototoxin from CL. botulinum type B cells].
    Ivanova LG; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):115-8. PubMed ID: 4218008
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparative isolation and immunochemical study of the O- and H-antigen components of Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Dec; 46(12):51-8. PubMed ID: 4986278
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isolation and properties of highly purified C1. botulinum toxin type E].
    Levdikova GA; Klimacheva LV; Ispolatovskaia MV; Bulatova TI; Anisimova LI
    Biokhimiia; 1979 Aug; 44(8):1392-400. PubMed ID: 115504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructure and characterization of an asporogenic mutant of Clostridium botulinum type E.
    Hawirko RZ; Chung KL; Emeruwa AC; Magnusson AJ
    Can J Microbiol; 1973 Feb; 19(2):281-4. PubMed ID: 4633199
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.
    Syuto B; Kubo S
    J Biol Chem; 1981 Apr; 256(8):3712-7. PubMed ID: 6783645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneities of two components of C2 toxin produced by Clostridium botulinum types C and D.
    Ohishi I; Okada Y
    J Gen Microbiol; 1986 Jan; 132(1):125-31. PubMed ID: 3086490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of homologous proteinase on Cl. botuliunum type B prototoxin].
    Ivanova LG; Blagoveshchenskii VA; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):115-9. PubMed ID: 4616560
    [No Abstract]   [Full Text] [Related]  

  • 14. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation and properties of a highly purified Clostridium botulinum type F toxin].
    Uvarova RN; Reshetnikova LN; Ispolatovskaia MV; Bulatova TI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):42-6. PubMed ID: 7004005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid precipitation of Clostridium botulinum type C and D toxins from whole culture by addition of ribonucleic acid as a precipitation aid.
    Iwasaki M; Sakaguchi G
    Infect Immun; 1978 Feb; 19(2):749-51. PubMed ID: 344224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alteration of the fractional composition and antigenic structure of botulin toxin E in the process of detoxication].
    Sycheva LP; Nemirovich-Danchenko MM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):117-20. PubMed ID: 4207091
    [No Abstract]   [Full Text] [Related]  

  • 20. [Discreteness of satellite bacterial toxins].
    Korovkina GV
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):111-6. PubMed ID: 190828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.